Evaluation of Block Duration in Type 2 Diabetes Patients

NCT01704612 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Type 2

Interventions

DRUG: ropivacaine

Sponsor

Pierre and Marie Curie University

Collaborators

[object Object]